Research Article
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Table 5
Association of type 2 diabetes mellitus with various predictors.
| | | No T2DM
(mean±SEM or
Absolute (relative)
counts | T2DM
(mean±SEM or
Absolute (relative)
counts | P | OR (univariate logistic regression) | 95%CI |
| | Age (years) | 58±1 | 63±1 | <0.0001 | 1.04 | 1.02-1.07 |
| | Male sex | 115 (42.6) | 45 (51.1) | 0.162 | 1.41 | 0.87-2.28 |
| | BMI (kg/m2) | 26.6±0.27 | 28.5±0.6 | 0.001 | 1.099 | 1.035-1.167 |
| | HCV RNA (IU/mL) | 2 776 629±347 176 | 2 937 405±434 013 | 0.259 | 1.225 | 0.862-1.741 |
| | Treatment experienced | 187 (69.3) | 65 (73.9) | 0.411 | 1.254 | 0.73-2.16 |
| | Elastography (kPa) | 12.5±0.86 | 13.6±1.3 | 0.5 | 1.007 | 0.99-1.03 |
| | F4 fibrosis (elastography) | 113 (42.2) | 54 (61.4) | 0.004 | 2.67 | 1.45-4.91 |
| | F3 fibrosis (elastography) | 60 (22.4) | 17 (19.3) | 0.227 | 1.58 | 0.75-3.34 |
| | Duration of HCV infection | 10.44±0.44 | 10.56±0.85 | 0.900 | 1.002 | 0.97-1.047 |
|
|
